HomeAbout

TL;DR CNBC


Healthy Returns: What we know about the next round of Covid vaccines - TL;DR CNBC

Healthy Returns: What we know about the next round of Covid vaccines

Publishing timestamp: 2024-06-12 13:40:14


Summary

FDA advises vaccine manufacturers to develop monovalent Covid shots targeting JN.1 strain for use in the U.S. starting this fall. Pfizer, Moderna, and Novavax have filed for FDA approval of updated vaccines targeting JN.1. White House announces Microsoft and Google will provide free and low-cost cybersecurity resources for rural hospitals to fend off growing cyberattacks in the healthcare sector.


Sentiment: NEUTRAL

Tickers: MRNANVAXGOOGLPFEMSFT

Keywords: united statesbusiness newshealth care industryalphabet incmoderna incnovavax incpfizer incmicrosoft corpbiotech and pharmaceuticals

Source: https://www.cnbc.com/2024/06/12/healthy-returns-what-we-know-about-the-next-round-of-covid-vaccines.html


Developed by Leo Phan